Cangrelor reduces the risk of ischemic complications in patients with single‐vessel and multi‐vessel disease undergoing percutaneous coronary intervention: Insights from the CHAMPION PHOENIX trial
暂无分享,去创建一个
Deepak L. Bhatt | M. Price | M. Desai | H. White | G. Stone | K. Mahaffey | V. Sundaram | R. Harrington | Lingyao Yang | C. Gibson | P. Steg | C. Hamm | P. Généreux | J. Prats | E. Deliargyris | Celina M. Yong | V. Ding | Freddy Abnousi | C. Yong | C. Gibson | F. Abnousi